Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms

The results of this retrospective study of 100 patients with myeloproliferative neoplasms treated with interferon-alpha show that the IL28B genotype may affect treatment outcome.

 European Journal of Haematology

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.